Shufro Rose & Co’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.92M Sell
41,228
-1,625
-4% -$122K 0.2% 64
2025
Q4
$3.38M Sell
42,853
-14,139
-25% -$1.12M 0.23% 59
2025
Q3
$4.58M Sell
56,992
-4,650
-8% -$366K 0.37% 49
2025
Q2
$4.95M Sell
61,642
-1,850
-3% -$143K 0.4% 48
2025
Q1
$5.1M Sell
63,492
-855
-1% -$71.1K 0.4% 49
2024
Q4
$5.27M Sell
64,347
-4,003
-6% -$333K 0.41% 47
2024
Q3
$4.8M Hold
68,350
0.39% 49
2024
Q2
$4.8M Sell
68,350
-1,060
-2% -$75.7K 0.39% 49
2024
Q1
$5.14M Sell
69,410
-1,446
-2% -$101K 0.42% 50
2023
Q4
$4.46M Sell
70,856
-1,225
-2% -$76.7K 0.42% 48
2023
Q3
$4.53M Sell
72,081
-1,796
-2% -$112K 0.43% 48
2023
Q2
$4.18M Buy
73,877
+6
+0% +$333 0.38% 50
2023
Q1
$4.28M Sell
73,871
-3,501
-5% -$236K 0.4% 51
2022
Q4
$5.6M Sell
77,372
-557
-0.7% -$39.9K 0.47% 52
2022
Q3
$4.74M Sell
77,929
-415
-0.5% -$26.5K 0.47% 47
2022
Q2
$4.92M Sell
78,344
-795
-1% -$52.6K 0.43% 52
2022
Q1
$5.56M Sell
79,139
-3,362
-4% -$227K 0.43% 53
2021
Q4
$5.16M Sell
82,501
-365
-0.4% -$22.9K 0.37% 55
2021
Q3
$5.12M Sell
82,866
-3,418
-4% -$206K 0.4% 53
2021
Q2
$5.16M Sell
86,284
-4,497
-5% -$285K 0.39% 53
2021
Q1
$5.52M Sell
90,781
-1,349
-1% -$74.4K 0.44% 48
2020
Q4
$4.33M Sell
92,130
-6,024
-6% -$261K 0.36% 54
2020
Q3
$3.65M Sell
98,154
-201,358
-67% -$7.64M 0.35% 52
2020
Q2
$10.9M Sell
299,512
-2,354
-0.8% -$81.9K 1.08% 27
2020
Q1
$9.23M Sell
301,866
-6,848
-2% -$304K 1.1% 25
2019
Q4
$15.7M Sell
308,714
-4,759
-2% -$230K 1.42% 24
2019
Q3
$14.8M Sell
313,473
-4,188
-1% -$200K 1.46% 25
2019
Q2
$15.8M Sell
317,661
-15,236
-5% -$716K 1.54% 22
2019
Q1
$14.2M Sell
332,897
-14,385
-4% -$636K 1.42% 22
2018
Q4
$14.3M Buy
347,282
+15,759
+5% +$676K 1.58% 21
2018
Q3
$15.5M Sell
331,523
-2,941
-0.9% -$134K 1.44% 18
2018
Q2
$14.6M Sell
334,464
-2,510
-0.7% -$117K 1.39% 21
2018
Q1
$15.5M Buy
336,974
+5,470
+2% +$265K 1.53% 20
2017
Q4
$16.8M Sell
331,504
-1,166
-0.4% -$61.4K 1.65% 18
2017
Q3
$17.3M Sell
332,670
-41,537
-11% -$2.02M 1.74% 17
2017
Q2
$18.3M Sell
374,207
-1,747
-0.5% -$81K 1.96% 11
2017
Q1
$17.7M Sell
375,954
-2,705
-0.7% -$129K 1.91% 11
2016
Q4
$18.2M Sell
378,659
-5,422
-1% -$249K 2.03% 12
2016
Q3
$15.2M Buy
384,081
+66,704
+21% +$2.51M 1.7% 15
2016
Q2
$11.3M Buy
317,377
+6,490
+2% +$253K 1.25% 23
2016
Q1
$12.2M Buy
310,887
+18,665
+6% +$698K 1.36% 19
2015
Q4
$12.6M Buy
292,222
+8,472
+3% +$373K 1.44% 19
2015
Q3
$11.9M Buy
283,750
+4,476
+2% +$209K 1.43% 20
2015
Q2
$13.9M Sell
279,274
-3,057
-1% -$145K 1.48% 18
2015
Q1
$12.7M Buy
282,331
+2,302
+0.8% +$103K 1.31% 23
2014
Q4
$13.5M Buy
280,029
+337
+0.1% +$16K 1.37% 21
2014
Q3
$13.4M Sell
279,692
-2,104
-0.7% -$102K 1.39% 19
2014
Q2
$14M Sell
281,796
-19,612
-7% -$918K 1.43% 18
2014
Q1
$14.2M Sell
301,408
-7,927
-3% -$364K 1.49% 17
2013
Q4
$14.9M Sell
309,335
-7,047
-2% -$316K 1.57% 17
2013
Q3
$13.2M Sell
316,382
-5,778
-2% -$249K 1.51% 17
2013
Q2
$13.1M Buy
+322,160
New +$11.8M 1.56% 18

Other funds holding MET

Shufro Rose & Co's MET Position: Q1 2026 in Review

Shufro Rose & Co reduced its MetLife (MET) stake by 3.8% in Q1 2026, selling an estimated $122K and leaving 41,228 shares worth $2.92M. The position accounts for 0.2% of the portfolio, ranked #64.

Shufro Rose & Co first reported a position in MET in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.3M in Q2 2017. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Shufro Rose & Co held 41,228 shares of MetLife worth $2.92M as of Q1 2026.
  • Shufro Rose & Co sold 1,625 MetLife shares in Q1 2026, an estimated $122K.
  • MetLife made up 0.2% of Shufro Rose & Co's portfolio in Q1 2026, its #64 holding.
  • Shufro Rose & Co first reported a position in MetLife in Q2 2013 and has held it in 52 quarters since.
  • Shufro Rose & Co's MetLife position peaked at $18.3M in Q2 2017.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Shufro Rose & Co's 13F filing for Q1 2026, filed 15 May 2026.